Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sick Kids researchers identify cancer stem cell for brain tumours

15.09.2003


A research team at The Hospital for Sick Children (HSC) and the University of Toronto (U of T), led by Dr. Peter Dirks, has identified for the first time a cancer stem cell in both malignant and benign brain tumours. This discovery may change how brain tumours are studied and how this deadly condition is treated in the future. This research is reported in the September 15, 2003 issue of the scientific journal Cancer Research.



"The discovery of a cancer stem cell for brain tumours means that only a small number of cells in a brain tumour have the ability to drive tumour growth. Many current cancer therapies may fail because they do not kill the cancer-sustaining stem cells. We now have to work on designing therapies that will attack these stem cells," said Dr. Peter Dirks, an HSC neurosurgeon and scientist-track investigator in the Developmental Biology Research Program, and an assistant professor of Neurosurgery at U of T.

Brain tumours are the leading cause of cancer mortality in children and remain difficult to cure despite advances in surgery and drug treatments. In adults, most brain tumours are also amongst the most sinister of cancers with formidable resistance to most therapies.


"We found that cancer stem cells from different tumour types, from aggressive malignant tumours to more slow-growing benign ones, share similar properties to each other as well as to normal brain stem cells. This suggests that mutations that lead to cancer formation may have originated in the brain’s own small numbers of stem cells," said Dr. Sheila Singh, the paper’s lead author, an HSC neurosurgery resident and U of T graduate student who is enrolled in HSC’s Clinician-Scientist Training Program.

The biology of the brain tumour stem cell may also shed light on metastases (tumour spread). The non-stem cells in the tumour may break off and spread, but may not be able to grow at distant sites. "It is possible that only the tumour stem cells will be able to grow at distant sites. If this is indeed the case, then the destruction of tumour stem cells may also be important for preventing metastatic disease," added Dr. Dirks.

Next stages of this research involve genetic studies of the purified cancer stem cells to find new genes that are critical for cancer stem cell growth. The identification of these genes is important for determining new targets for brain tumour therapy. Dr. Dirks’ laboratory is also investigating whether a patient’s cancer stem cells alone can cause growth of the patient’s tumour in a mouse. If the tumour resembles the patient’s original tumour, this may lead to a mouse model for the tumour type.


Dr. Dirks’ laboratory is located in the Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children. Other members of the research team included Dr. Ian Clarke, Dr. Mizuhiko Terasaki, Victoria Bonn, and Dr. Cynthia Hawkins, all from The Hospital for Sick Children, and Dr. Jeremy Squire from the Ontario Cancer Institute and the University of Toronto.

This research was supported by The Terry Fox Foundation through the National Cancer Institute of Canada, the Neurosurgery Research and Education Foundation with funds from the American Brain Tumor Association, and The Hospital for Sick Children Foundation including gifts from Arthur and Sonia Labatt and the Baker family.

The Hospital for Sick Children, affiliated with the University of Toronto, is Canada’s most research-intensive hospital and the largest centre dedicated to improving children’s health in the country. Its mission is to provide the best in family-centred, compassionate care, to lead in scientific and clinical advancement, and to prepare the next generation of leaders in child health. For more information, please visit http://www.sickkids.ca.

Laura Greer | EurekAlert!
Further information:
http://www.utoronto.ca/
http://www.sickkids.ca

More articles from Health and Medicine:

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

nachricht Flexible sensors can detect movement in GI tract
11.10.2017 | Massachusetts Institute of Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Ocean atmosphere rife with microbes

17.10.2017 | Life Sciences

Neutrons observe vitamin B6-dependent enzyme activity useful for drug development

17.10.2017 | Life Sciences

NASA finds newly formed tropical storm lan over open waters

17.10.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>